314
Participants
Start Date
September 30, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
October 31, 2015
COBI
150 mg tablet administered orally with food once daily
DRV
800 mg (2 x 400 mg tablets) administered orally with food once daily
NRTIs
Participants will receive 2 nucleoside analogue reverse transcriptase inhibitors (NRTIs) selected by the investigator after resistance testing at screening and administered according to prescribing information. NRTIs may include emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF), zidovudine+FTC/TDF, abacavir (ABC)+TDF, ABC+FTC/TDF, ABC+lamivudine (3TC), or didanosine (DDI)+FTC.
Beth Israel Medical Center, New York
Greiger Clinic, Mount Vernon
North Shore University Hospital / Division of Infectious Diseases, Manhasset
University of PA, Philadelphia
Philadelphia FIGHT, Philadelphia
Dupont Circle Physician's Group, Washington D.C.
Whitman-Walker Health, Washington D.C.
Johns Hopkins University, Lutherville
Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID), Annandale
Wake Forest University Health Services, Winston-Salem
Duke University Medical Center, Durham
Carolinas Medical Center-Myer's Park Infectious Disease Clinic, Charlotte
Infectious Disease Specialists of Atlanta, Decatur
Atlanta ID group, Atlanta
Mercer University, Macon
Orlando Immunology Center, Orlando
Wohlfeiler, Piperato and Associates, LLC, Miami Beach
Gary J. Richmond,M.D., P.A., Fort Lauderdale
St. Joseph's Comprehensive Research Institute, Tampa
Midway Immunology and Research Center, Ft. Pierce
Be Well Medical Center, Berkley
Henry Ford Hospital, Detroit
HIV Program Hennepin County Medical Center, Minneapolis
Howard Brown Health Center, Chicago
Northstar Medical Center, Chicago
Central West Clinical Research Inc, Saint Louis
Trinity Health and Wellness Center/AIDS Arms, Inc., Dallas
Southwest Infectious Disease Clinical Research, Inc., Dallas
DCOL Center for Clinical Research, Longview
Tarrant County Infectious Disease, Fort Worth
Therapeutic Concepts, PA, Houston
Gordon Crofoot MD, PA, Houston
Central Texas Clinical Research, Austin
Apex Research LLC, Denver
Spectrum Medical Group, Phoenix
Swedish Medical Center, Seattle
Peter J Ruane MD Inc., Los Angeles
Anthony Mills MD Inc, Los Angeles
Long Beach Education and Research Consultants, PC, Long Beach
La Playa Medical Group and Clinical Research, San Diego
Metropolis Medical, San Francisco
Stanford University, Palo Alto
Kaiser Permanente Medical Group, Sacramento
Hawaii Center for AIDS, University of Hawaii, Honolulu
Community Research Initiative of New England, Boston
Saint Michael's Medical Center, Newark
South Jersey Infectious Disease, Somers Point
Miriam Hospital, Providence
Clinical Research Puerto Rico, San Juan
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
Gilead Sciences
INDUSTRY